Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine

https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piz010/5372494

Supplementary Table 6:

+------------------------------+------------------+-----------------+
|            n (%)             | MMR-RIT (N=3714) | MMR II (N=1289) |
+------------------------------+------------------+-----------------+
| Unsolicited AEs (≥1 symptom) | 1857 (50.0)      | 618 (47.9)      |
|  Grade 3                     | 225 (6.1)        | 85 (6.6)        |
| SAEs (any, ≥1 SAE)           | 77 (2.1)         | 25 (1.9)        |
| AEs prompting ER visit       | 375 (10.1)       | 134 (10.4)      |
| NOCDs (any, ≥1 NOCD)         | 128 (3.4)        | 48 (3.7)        |
+------------------------------+------------------+-----------------+

AE, adverse event; ER, emergency room; N, number of children with the documented dose; n (%), number (percentage) of children reporting the AE at least once; NOCDs, new onset chronic diseases (see definition in Patients and methods); SAE, serious AE.
Grade 3 unsolicited AEs were those preventing normal, everyday activities.